The formulation of a safe and efficient drug delivery system, which can overcome the limitations faced by conventional methods of treatment, is seen as the next step towards successfully treating diseases such as cancer. Nanoparticles have gained much attention due to their desirable characteristics, facile synthesis and their adaptability in applications across various fields. Of these, gold nanoparticles (AuNP's) have emerged as potential vehicles for the delivery of chemotherapeutic drugs due to favourable attributes such as their apparent low toxicity, high surface area, biocompatibility, high loading capacity and ease of surface modification. It was hypothesized that gold nanoparticles used as delivery vehicles would improve anticancer activity of the drug towards cancerous cell lines, due to the ability of the nanoparticles in penetrating the leaky vasculature structure of cancerous tissue, this coupled with the mildly acidic pH of cancerous cells would result in the release of the anti-cancer drugs. Due to this there would be a decrease in cytotoxic effects towards noncancerous cell lines. This study involved the chemical synthesis of AuNP's via a modified Turkevich method. Subsequently, AuNP's were functionalized with the cationic polymer chitosan which encapsulated two anticancer drugs ie. 5-Fluorouracil (5-FU) and Doxorubicin (Dox) respectively, followed by functionalization with human transferrin. Nanoparticles and nanocomposites were fully characterized using ICP, FTIR, HR-TEM, UV-vis spectroscopy and Nanoparticle Tracking Analysis (NTA). To investigate the ability of the nanocomplexes in enhancing the activity of the selected drugs towards HeLa (Cervical adenocarcinoma), a cancerous cell line and lowering the cytotoxic effects of the drugs towards HEK293 (embryonic kidney), a noncancerous cell line, two in vitro cytotoxicity assays were performed.
